Lv3
300 积分 2022-01-11 加入
Perspectives on current approaches to virtual screening in drug discovery
6小时前
已完结
PCSK9 inhibitors: a patent review 2018-2023
10小时前
已完结
Fragment-based drug discovery: Small fragments, big impact − Success stories of approved oncology therapeutics
1天前
已完结
Covalent Library Screening by Targeted Mass Spectrometry for Rapid Binding Site Identification
8天前
已完结
Bridging the gap between target-based and phenotypic-based drug discovery
15天前
已完结
Challenges and Prospects of DNA-Encoded Library Data Interpretation
15天前
已完结
An Analysis of Successful Hit-to-Clinical Candidate Pairs
15天前
已完结
Drug Discovery Stories
18天前
已完结
Beyond First-Generation KRAS Inhibitors: BBO-8520 Tests the Dual Mechanism Hypothesis
18天前
已关闭
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
1个月前
已完结
皖公网安备34019202002308
